NO992526L - Cephalosporin-derivater - Google Patents

Cephalosporin-derivater

Info

Publication number
NO992526L
NO992526L NO992526A NO992526A NO992526L NO 992526 L NO992526 L NO 992526L NO 992526 A NO992526 A NO 992526A NO 992526 A NO992526 A NO 992526A NO 992526 L NO992526 L NO 992526L
Authority
NO
Norway
Prior art keywords
group
halogen
hydrogen
derivatives
alkyl group
Prior art date
Application number
NO992526A
Other languages
English (en)
Norwegian (no)
Other versions
NO992526D0 (no
Inventor
Dane M Springer
Bing Y Luh
Andrea Stanley V D
Thomas W Hudyma
Oak K Kim
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO992526L publication Critical patent/NO992526L/no
Publication of NO992526D0 publication Critical patent/NO992526D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO992526A 1996-11-27 1999-05-26 Cephalosporin-derivater NO992526D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3404696P 1996-11-27 1996-11-27
PCT/US1997/021785 WO1998023621A1 (en) 1996-11-27 1997-11-21 Cephalosporin derivatives

Publications (2)

Publication Number Publication Date
NO992526L true NO992526L (no) 1999-05-26
NO992526D0 NO992526D0 (no) 1999-05-26

Family

ID=21873971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992526A NO992526D0 (no) 1996-11-27 1999-05-26 Cephalosporin-derivater

Country Status (17)

Country Link
EP (1) EP0966472A1 (zh)
JP (1) JP2001506607A (zh)
KR (1) KR20000057283A (zh)
CN (1) CN1238775A (zh)
AR (1) AR010650A1 (zh)
AU (1) AU734948B2 (zh)
BR (1) BR9713350A (zh)
CA (1) CA2272717A1 (zh)
CZ (1) CZ185399A3 (zh)
HU (1) HUP9903621A3 (zh)
IL (1) IL129437A0 (zh)
NO (1) NO992526D0 (zh)
NZ (1) NZ335892A (zh)
PL (1) PL334558A1 (zh)
TW (1) TW414796B (zh)
WO (1) WO1998023621A1 (zh)
ZA (1) ZA9710662B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265394B1 (en) * 1997-07-31 2001-07-24 Bristol-Myers Squibb Company Bis quaternary MRSA cephem derivatives
KR20020085176A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085180A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030071311A (ko) * 2002-02-28 2003-09-03 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조방법
EP2709983B1 (en) * 2011-05-18 2018-04-18 Syngenta Participations AG Insecticidal compounds based on arylthioacetamide derivatives
CN105131018B (zh) * 2015-09-23 2017-12-26 浙江华方药业股份有限公司 一种头孢替唑酸的制备方法
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345366A (en) * 1967-02-15 1967-10-03 American Cyanamid Co Substituted 7-acetylamino cephalosporanic acids
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US5567698A (en) * 1995-02-15 1996-10-22 Bristol-Myers Squibb Company Pyridinium thiomethyl substituted chepholosporin derivatives
US5620969A (en) * 1995-04-25 1997-04-15 Bristol-Myers Squibb Company Cephalosporin derviatives
US5734047A (en) * 1995-12-20 1998-03-31 Bristol-Myers Squibb Company Cephalosporin derivatives

Also Published As

Publication number Publication date
CZ185399A3 (cs) 1999-08-11
CN1238775A (zh) 1999-12-15
PL334558A1 (en) 2000-03-13
HUP9903621A3 (en) 2001-05-28
TW414796B (en) 2000-12-11
HUP9903621A2 (hu) 2000-04-28
KR20000057283A (ko) 2000-09-15
BR9713350A (pt) 2000-01-25
IL129437A0 (en) 2000-02-17
JP2001506607A (ja) 2001-05-22
NZ335892A (en) 2001-07-27
EP0966472A1 (en) 1999-12-29
EP0966472A4 (zh) 1999-12-29
AU734948B2 (en) 2001-06-28
AU5365298A (en) 1998-06-22
CA2272717A1 (en) 1998-06-04
AR010650A1 (es) 2000-06-28
ZA9710662B (en) 1999-05-26
NO992526D0 (no) 1999-05-26
WO1998023621A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
DE69331089D1 (de) Beta-Laktam und Cepham Verbindungen und Ihre Herstellung
NO992526L (no) Cephalosporin-derivater
ATE110729T1 (de) Cephalosporinverbindungen, verfahren zu ihrer herstellung und antibakterielle mittel.
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
WO2001003685A3 (en) Novel prodrugs for antimicrobial amidines
FI864825A (fi) Cefalosporinderivat.
EP0376724A3 (en) Cephalosporin compounds
FI924934A0 (fi) Nya ftalaziner som innehaoller en eter- eller tioetergruppering i 1-staellning och foerfarande foer deras framstaellning
EP0214600A3 (en) Cephalosporin derivatives
ES455404A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
GB1531141A (en) Beta-lactam antibiotics
AU2293688A (en) Novel aminoalkyl-substituted heterocyclic sulfur compounds
DE3787030D1 (de) 1-carboxy-1-vinyloxyiminoaminothiazol-cephalosporin-derivate und deren herstellung.
NO171502C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive thiadiazolylacetamidcefem-derivater
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
DE69523058D1 (de) Carbapenem-derivate
ES8405399A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
ES8507151A1 (es) Un metodo de producir derivados de cefalosporina
CA2155837A1 (en) Benzopyrans as potassium channel openers
SE7709646L (sv) Antibakteriella medel
SE8504538D0 (sv) Carbapenem antibiotics
RU99113359A (ru) Производные цефалоспорина
SE8104308L (sv) Nya foreningar med antibiotisk verkan
DK366982A (da) Cephalosporinderivater og fremgangsmaade til deres fremstilling
IE43541L (en) 3-(heterocyclic) thiomethyl cephalosporin derivatives.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application